TiHo Bibliothek elib - Tierärztliche Hochschule Hannover

LITERATURVERZEICHNIS
LIU, J.Y.W., THOM, M., CATARINO, C.B., MARTINIAN, L., FIGARELLABRANGER, D.,
BARTOLOMEI, F., KOEPP, M., SISODIYA, S.M., 2012. Neuropathology of the blood–brain
barrier and pharmaco-resistance in human epilepsy. Brain. 135: 3115-3133.
LIU, X., CHEN, C., SMITH, B., 2008. Progress in brain permeation evaluation in drug discovery and
development. J Pharmacol Exp Ther 325: 349-356.
LOMBARDO, L., PELLITTERI, R., BALAZY, M., CARDILE, V., 2008. Induction of nuclear receptors
and drug resistance in the brain microvascular endothelial cells treated with antiepileptic
drugs. Curr. Neurovasc. Res. 5: 82-92.
LOO, T.W., CLARKE, D.M., 1995. Membrane topology of a cysteine-less mutant of human P-
glycoprotein. J Biol Chem. 270: 843-848.
LOO, T.W., CLARKE, D.M., 1999. The transmembrane domains of the human multidrug resistance P-
glycoprotein are sufficient to mediate drug binding and trafficking to the cell surface. J Biol
Chem. 274: 24759-2465.
LOPEZ-RAMIREZ, M.A., FISCHER, R., TORRES-BADILLO, C.C., DAVIES, H.A., LOGAN, K.,
PFIZENMAIER, K., MALE, D.K., SHARRACK, B., ROMERO, I.A., 2012. Role of caspases in
cytokine-induced barrier breakdown in human brain endothelial cells. J Immunol. 189: 3130-
3139.
LÖSCHER, W., 1994. Neue Antiepileptika - ein Fortschritt für die Behandlung epileptischer Tiere?
Kleintierpraxis 39: 239-258.
LÖSCHER, W., 2005. Mechanisms of drug resistance. Epileptic Disord. 7 (Suppl. 1): S3-S9.
LÖSCHER, W., BRANDT, C., 2010. Prevention or modification of epileptogenesis after brain insults:
experimental approaches and translational research. Pharmacological Rev. 62: 668-700.
LÖSCHER, W., FREY, H.H., 1984. Kinetics of penetration of common antiepileptics drugs into
cerebrospinal fluid. Epilepsia 25: 346–352.
LÖSCHER, W., LANGER, O., 2010. Imaging of P-glycoprotein function and expression to elucidate
mechanisms of pharmacoresistance in epilepsy. Curr Top Med Chem. 10: 1785-1791.
LÖSCHER, W., POTSCHKA, H., 2002. Role of multidrug transporters in pharmacoresistance to
antiepileptic drugs. J. Pharmacol. Exp. Ther. 301: 7-14.
LÖSCHER W, POTSCHKA, H., 2005a. Role of drug efflux transporters in the brain for drug disposition
and treatment of brain diseases. Prog. Neurobiol. 76: 22-76.
LÖSCHER, W., POTSCHKA, H., 2005b. Drug resistance in brain diseases and the role of drug efflux
transporters. Nat. Rev. Neurosci. 6: 591-602.
LÖSCHER, W., POTSCHKA, H., 2005c. Blood-Brain Barrier Active Efflux Transporters: ATP-Binding
Cassette Gene Family. NeuroRx. 2: 86–98.
LÖSCHER, W., SCHMIDT, D., 2006a. New Horizons in the development of antiepileptic drugs.
Innovative strategies. Epilepsy Res. 69: 183-272.
LÖSCHER, W., SCHMIDT, D., 2006b. Experimental and clinical evidence for loss of effect (tolerance)
during prolonged treatment with antiepileptic drugs. Epilepsia 47: 1253-1284.
LÖSCHER, W., SCHMIDT, D., 2011 Modern antiepileptic drug development has failed to deliver: ways
out of the current dilemma. Epilepsia 52: 657– 678.
193